Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

K2 Therapeutics Appoints Dr. Ying Huang As Chief Executive Officer

PRIVATEAug 11, 2026about 3 hours ago

Position

Chief Executive Officer

Company

K2 Therapeutics

Dr. Ying Huang
SingaporeBiotechnology

Description

K2 Therapeutics has announced the appointment of Dr. Ying Huang as its Chief Executive Officer. The company, founded by MPM BioImpact, focuses on advancing biotechnology innovation with a global approach.

Company Information

Company

K2 Therapeutics

Location

Singapore

About

K2 Therapeutics is a Singapore-based biotech company focused on identifying and translating assets into medicines. Founded by MPM BioImpact, it aims to unlock potential in medicine to improve and extend lives. The company operates under a hub-and-spoke model to gain a competitive edge in the biotech industry.

Predictive Intelligence
Strategic

ML-powered predictions for K2 Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.